Improvement In Clinic Efficiency, Patient Satisfaction, And Overcoming Unique Challenges In The Era Of Covid-19 With Implementation Of Subcutaneous Daratumumab In Patients With Multiple Myeloma (Mm) And Light Chain (Al) Amyloidosis

BLOOD(2020)

引用 1|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要